Millennium reports 1.3% stake in Cabaletta Bio
Cabaletta Bio, Inc. is reported as having a significant shareholder group led by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.
Rhea-AI Filing Summary
Cabaletta Bio, Inc. is reported as having a significant shareholder group led by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. These reporting persons collectively report beneficial ownership of 2,068,491 shares of Cabaletta Bio common stock, representing 1.3% of the class.
The filing states that the reporting persons have no sole voting or dispositive power over these shares, but hold shared voting and shared dispositive power over 2,068,491 shares. The securities are held through entities over which Millennium Management LLC and related managers exercise voting control and investment discretion, and the reporting persons state that this disclosure should not be construed as an admission of beneficial ownership. They also indicate that they now hold 5 percent or less of Cabaletta Bio’s common stock.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficial ownership financial
Schedule 13G/A regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in CABA does Millennium Management report in this Schedule 13G/A?
Who are the reporting persons in Cabaletta Bio (CABA)’s Schedule 13G/A?
What percentage of Cabaletta Bio (CABA) common stock is reported as owned?
How do Millennium entities describe their beneficial ownership of Cabaletta Bio (CABA)?
What type of security in CABA is covered by this Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.